FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed in pharmaceutical composition for external application for treatment or prevention of onichomycosis or prevention of hyperkeratotic tricophytosis, including: (i) luliconazole, represented by the following structural formula
(1)
and/or its salt; (ii) α-hydroxicarbonic acid and/or its salt and (iii) benzyl alcohol.
EFFECT: increase of penetration (absorption) of luliconazole through nail.
7 cl, 6 dwg, 15 tbl, 24 ex
